clinical trials

Palatin enrols first subject in Phase II ulcerative colitis therapy trial
Clinical Trials Arena
Fri, 10/21/22 - 10:41 am
Palatin Technologies
ulcerative colitis
PL8177
clinical trials
GSK’s Shingrix showed to offer ten years of shingles protection in study
Clinical Trials Arena
Thu, 10/20/22 - 10:38 am
GSK
vaccines
shingles
Shingrix
clinical trials
AM-Pharma, once a Pfizer takeover target, flunks phase 3 kidney injury trial
Fierce Biotech
Thu, 10/20/22 - 10:35 am
AM-Pharma
clinical trials
kidney injury
Pfizer
Apogenix’s asunercept shown to offer benefits in Phase II Covid-19 trial
Clinical Trials Arena
Thu, 10/20/22 - 10:33 am
Apogenix
clinical trials
asunercept
COVID-19
Study: Older adults underrepresented in trials of drugs they may regularly use
RAPS.org
Wed, 10/19/22 - 10:49 pm
clinical trials
elderly
Gilead touts Veklury resilience against mutated coronavirus, plots phase 3 for new COVID oral antiviral
Fierce Pharma
Wed, 10/19/22 - 11:03 am
Gilead Sciences
COVID-19
clinical trials
Veklury
Teva reports data from Huntington’s disease-linked chorea trial
Clinical Trials Arena
Wed, 10/19/22 - 10:54 am
Teva Pharmaceutical
Austedo
clinical trials
chorea
Huntington's disease
GSK decides time is right to pay Tempus $70M to expand access to patient data library
Fierce Biotech
Tue, 10/18/22 - 10:58 am
GSK
Tempus
drug development
clinical trials
artificial intelligence
Salarius hits pause on enrollment of lead sarcoma asset trial after patient death
Fierce Biotech
Tue, 10/18/22 - 10:34 am
Salarius
clinical trials
sarcomas
seclidemstat
Milestone's Nasal Spray for PSVT Hits the Mark in Phase III
BioSpace
Mon, 10/17/22 - 11:40 pm
Milestone Pharma
PSVT
etripamil
clinical trials
Underrepresentation of women in early-stage clinical trials
Clinical Trials Arena
Mon, 10/17/22 - 11:27 pm
clinical trials
women
gender diversity
Things don't look good for NGM's Merck-partnered eye asset as phase 2 fail sends stock plummeting
Fierce Biotech
Mon, 10/17/22 - 11:17 pm
NCM Biopharmaceuticals
clinical trials
Merck
age-related macular degeneration
Sage, Biogen post fresh phase 3 depression data as FDA filing nears completion
Fierce Biotech
Mon, 10/17/22 - 10:39 am
SAGE Therapeutics
Biogen
zuranolone
postpartum depression
clinical trials
Relmada’s MDD Drug Misses Endpoint, Marred by “Paradoxical Results”
BioSpace
Thu, 10/13/22 - 11:45 pm
Relmada
REL-1017
major depressive disorder
clinical trials
GSK hits back in high-stakes RSV vaccine game, posting phase 3 data that suggest it has edge on Pfizer
Fierce Biotech
Thu, 10/13/22 - 09:47 am
GSK
RSV
vaccines
clinical trials
Pfizer
JNJ
Moderna Therapeutics
RSVPreF3
Janux doses first subject in Phase I prostate cancer therapy trial
Clinical Trials Arena
Thu, 10/13/22 - 09:43 am
Janux Therapeutics
JANX007
prostate cancer
clinical trials
Software surveillance company VigiLanz rolls out clinical trial enrollment tool
Fierce Biotech
Thu, 10/13/22 - 09:40 am
VigiLanz
clinical trials
clinical trial enrollment
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Yahoo/Businesswire
Thu, 10/13/22 - 09:26 am
Pfizer
BioNTech
clinical trials
COVID-19
vaccines
boosters
bivalent boosters
Dupixent Shows Promise as First Treatment for Childhood EoE
BioSpace
Wed, 10/12/22 - 10:33 am
Dupixent
Sanofi
Regeneron
pediatric
clinical trials
eosinophilic esophagitis
TauRx’s HMTM could be the first anti-tau disease-modifying drug for Alzheimer’s
Clinical Trials Arena
Tue, 10/11/22 - 04:17 pm
Alzheimer's disease
TauRx
clinical trials
HMTM

Pages